✦ LIBER ✦

Isolated limb perfusion with melphalan for femoral metastases of breast cancer: Case report

✍ Scribed by E.M. Noorda; B.C. Vrouenraets; O.E. Nieweg; H.M. Pinedo; B.B.R. Kroon

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 130 KB
Volume: 81
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.10174

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A clinical and pharmacokinetic study of

A clinical and pharmacokinetic study of isolated limb perfusion with heat and melphalan for melanoma

✍ David R. Minor; Robert E. Allen; David Alberts; Yei-Mei Peng; George Tardelli; J 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 607 KB

Pharmacokinetics of isolated lung perfus

Pharmacokinetics of isolated lung perfusion with melphalan for resectable pulmonary metastases, a phase I and extension trial

✍ Marco JJ H. Grootenboers; Jeroen M.H. Hendriks; Wim J. van Boven; Catherijne A.J 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

Isolated limb perfusion with tumor necro

Isolated limb perfusion with tumor necrosis factor-α and melphalan for patients with unresectable soft tissue sarcoma of the extremities

✍ Eva M. Noorda; Bart C. Vrouenraets; Omgo E. Nieweg; Frits van Coevorden; Gooike 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract ## BACKGROUND Since 1992, isolated limb perfusion (ILP) with tumor necrosis factor‐α (TNFα) and melphalan has been used for the treatment of patients with unresectable soft tissue sarcomas of the extremities. The authors retrospectively studied the results of limb salvage surgery using

Treatment of primary or relapsing limb c

Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalan

✍ Maurizio Vaglini; Filiberto Belli; Mario Ammatuna; Maria Grazia Inglese; Renato 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 834 KB

Long-term outcome of isolated limb perfu

Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases

✍ J. P. Deroose; D. J. Grünhagen; A. N. van Geel; J. H. W. de Wilt; A. M. M. Egger 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 1 views

Outcome and prognostic factor analysis o

Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-α and melphalan for limb-threatening soft tissue sarcoma

✍ Dirk J. Grunhagen; Johannes H. W. de Wilt; Wilfried J. Graveland; Cornelis Verho 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB